$0.90
-0.03 | -3.08%
-0.03 | -3.08%
Today's Range:
0.90 -
0.98
OXGN Avg. Daily Volume:
246,300
05/29/12 - 3:58 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.93 |
| 52 Week High | 5.36 |
| 52 Week Low | 0.82 |
| Avg. Daily Vol. (Mil) | 0.25 |
| Beta (3 year) | 2.90 |
| Share Related Items | |
| Mkt Cap (Mil) | 15.02 |
| Shares Out (Mil) | 16.17 |
| Float (Mil) | 16.15 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.50 |
| Current Ratio | 5.90 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 131.76 |
| Price/Book | 2.00 |
| Price/Cash Flow | -1.40 |
| Per Share Data | |
| Earnings | -0.81 |
| Sales | 0.01 |
| Book Value | 0.46 |
| Cash Flow | -0.65 |
| Business Summary | |
|---|---|
| OXiGENE, Inc. incorporated in 1988. It's a clinical-stage; Biopharmaceutical Company developing novel therapeutics to treat cancer, its main focus is the development of product candidates referred to as vascular disrupting agents. | |
| General Information | |
| 701 Gateway Boulevard
Suite 210 South San Francisc, CA 94080 |
|
| www.oxigene.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 11 | |
| CEO: Dr. Peter J. Langecker,M | |
| Short Interest | |
| Current Month (Mil) | 0.73 |
| Previous Month (Mil) | 0.75 |
| Short Interest Ratio (Days) | 3.20 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -118.80 |
| Return on Investments | -142.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,580.69 | 1,332.42 | 2,870.99 | 17.31 |
Oil *
106.79
|
|
UP
125.86 |
UP
14.60 |
UP
33.46 |
DOWN
0.14 |
10 Yr
1.73%
SPDR Gold
151.02
|
|
+1.01%
|
+1.11%
|
+1.18%
|
-0.80%
|
Data delayed 20 minutes |
Connect with TheStreet